Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
12/1999
12/29/1999CA2335502A1 Sonophoresis method and apparatus
12/29/1999CA2330026A1 Compositions and methods for delivery of agents for altering neuronal growth, regeneration, and survival
12/28/1999US6008241 A photodynamic therapy
12/28/1999US6008211 Photoactivatable compounds comprising benzochlorin and furocoumarin
12/28/1999US6007476 Non-particle, non-photonic device and method for affecting angiogenesis
12/23/1999WO1999065517A2 Therapeutic compositions that produce an immune response by altering the antigen
12/23/1999DE19827417A1 New material for differentially modifying the optical activities of different cells comprises a mixture of a base material and a modification material
12/23/1999CA2333221A1 Therapeutic compositions that produce an immune response by altering the antigen
12/22/1999EP0965350A1 Method of exciting photosensitive material
12/22/1999EP0964679A1 Method for the treatment of neurological or neuropsychiatric disorders
12/22/1999EP0910385A4 Sensitization of cells to radiation and chemotherapy
12/21/1999US6004742 Method for inactivation of pathogens in platelets using 4' and 5' primary amino-substituted psoralens
12/21/1999US6004741 Method for the photoactivation of 4' and 5' primary aminoalkyl psoralens in platelet preparations
12/21/1999US6004588 A stone which emits far-infrared radiation contains silicon, aluminum, potassium and iron; used for medicine and food
12/21/1999US6004579 Aging inhibition; wound healing agent; preserving organs; treating dermatological conditions such as wrinkling, sagging, baldness, psoriasis
12/21/1999US6004533 Radionuclide labeling of vitamin B12 and coenzymes thereof
12/16/1999WO1999063900A1 Improved methods and apparatus for multi-photon photo-activation of therapeutic agents
12/16/1999CA2333175A1 Improved methods and apparatus for multi-photon photo-activation of therapeutic agents
12/15/1999EP0414730B1 Chemical Compounds and pharmaceutical compositions capable of releasing a drug
12/14/1999US6002961 Transdermal protein delivery using low-frequency sonophoresis
12/14/1999US6001335 Synthesizing a lipid vesicle having a gas encapsulated therein for ultrasonic imaging, by subjecting a solvent-free composition of a gaseous precursor and lipid in aqueous medium to a first pressure, then a second lower pressure
12/14/1999CA2172607C Phorbine derivatives and their use in the diagnosis and therapy of cancer
12/09/1999WO1999062551A1 Texaphyrin conjugates and uses thereof
12/09/1999WO1999062512A1 3-, 8-substituted deuteroporphyrin derivatives, pharmaceutical substances containing the same, method for the production and use thereof in photodynamic therapy and mri diagnosis
12/09/1999WO1999054445A3 Combination therapy using nucleic acids and conventional drugs
12/09/1999WO1999054444A3 Combination therapy using nucleic acids and radio therapy
12/09/1999WO1998025648A3 Use of a texaphyrin in ocular diagnosis and therapy
12/09/1999DE19825512A1 3-,8-subsituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung in der photodynamischen Therapie und MRI-Diagnostik 3-, 8-subsituierte Deuteroporphyrinderivate, pharmaceutical compositions containing them, processes for their preparation and their use in photodynamic therapy and MRI diagnostics
12/09/1999CA2334809A1 Texaphyrin conjugates and uses thereof
12/07/1999US5998597 The treatment of a particular volume of plant or animal tissue comprising the steps of treating the plant or animal tissue with at least one photo-active molecular agent.
12/07/1999US5997842 Radionuclide excited phosphorescent material for administering PDT
12/02/1999WO1999061085A2 Method and compositions for treatment of cancers
12/02/1999WO1999061058A1 Method of altering heartbeat
12/01/1999EP0959879A1 Photodynamic therapy for the treatment of osteoarthritis
11/1999
11/30/1999US5994535 Water soluble texaphyrin metal complex preparation
11/25/1999WO1999059975A1 Fused tricyclic compounds which inhibit parp activity
11/25/1999WO1999059715A1 Microencapsulation and electrostatic processing device
11/25/1999WO1999059714A1 Microencapsulation and electrostatic processing method
11/25/1999WO1999059641A1 Use of long-wavelength electromagnetic radiation of diagnosis
11/25/1999WO1999059578A1 Triterpene compositions and methods for use thereof
11/25/1999WO1999059556A1 Externally triggered microcapsules
11/25/1999WO1999059555A1 Microencapsulated bioactive agents and method of making
11/25/1999WO1999059554A1 In situ activation of microcapsules
11/25/1999CA2332239A1 Fused tricyclic compounds which inhibit parp activity
11/24/1999EP0892632A4 Compositions useful in the phototherapeutic treatment of proliferative skin disorders
11/23/1999US5990149 Photodynamic therapy; using triacid form of the monohydrobenzoporphyrin class; antitumor, carcinogenic, arthritic agents; atherosclerosis; restenosis; blood infections; skin disorders; vision defects
11/18/1999WO1999058570A2 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use therefor for diagnosis and therapy of tumors and diseases associated with angiogenesis
11/18/1999WO1999058149A1 Controlled activation of targeted radionuclides
11/18/1999WO1999058148A1 The method of treatment of locally propagated mammary gland cancer
11/18/1999WO1999051202A3 Quinolone containing liposomes and their use as antibacterial agents
11/17/1999EP0955998A2 Microparticles containing active substances, agents containing the same, their use in ultrasound-controlled releasing of active substances as well as the method for their production
11/17/1999EP0955878A1 Electro-medical apparatus
11/16/1999US5986090 Metallized porphyrins
11/16/1999US5986076 A conjugate is formed by bonding a bioreactive agent to the therapeutic agent with a bond that is selectively cleavable with electromagnetic radiation; useful for controlled release of drugs to treat the disorder
11/16/1999US5985331 Methods of use of phthalocyanines to inactivate blood borne parasites
11/16/1999US5985266 Sensitize tumors, retrovirus comprises operatively linked to a promoter a gene encoding a viral thymidine kinase; such that said tumor cells become transduced by said retrovirus and express said viral thymidine kinase gene;
11/16/1999US5985246 Contrast agents for ultrasonic imaging and methods for preparing the same
11/16/1999US5984887 Photopheresis treatment of leukocytes
11/11/1999DE19819975A1 Unit for simultaneous photodynamic and hyperthermal therapy of tumors avoiding harm to surrounding tissues
11/10/1999EP0954336A2 Membrane incorporation of texaphyrins
11/09/1999US5981163 Irradiating extracorporeal biological compositions such as blood and blood products in presence of quencher compound(s); deactivates viruses without substantial disruption or deactivation of cells and labile proteins
11/09/1999US5980950 Thrombolytic agents and methods of treatment for thrombosis
11/09/1999US5980934 A card-shaped housings supporting the transdermal delivery device comprising a processor to receive delivery data via an interface to inhibit delivery of an inappropriate substance
11/04/1999WO1999055383A2 Improvements in or relating to diagnostic/therapeutic agents
11/04/1999CA2329778A1 Improvements in or relating to diagnostic/therapeutic agents
11/03/1999EP0952873A1 Targeted hysteresis hyperthermia as a method for treating diseased tissue
11/03/1999EP0952850A2 Microporation of tissue for delivery of bioactive agents
11/03/1999CN1233470A Electrolysis of water resulting in reduction of fat content in human liver
11/02/1999US5976884 Methods for quantifying photoreactions in light activated materials
10/1999
10/28/1999WO1999054445A2 Combination therapy using nucleic acids and conventional drugs
10/28/1999WO1999054444A2 Combination therapy using nucleic acids and radio therapy
10/28/1999WO1999053965A1 Improvements in or relating to contrast agents
10/28/1999WO1999053963A1 Improvements in or relating to contrast agents
10/28/1999WO1999053962A1 Solution for diagnosing or treating tissue pathologies
10/28/1999CA2329175A1 Improvements in or relating to contrast agents
10/28/1999CA2325596A1 Combination therapy using nucleic acids and radio therapy
10/28/1999CA2325561A1 Combination therapy using nucleic acids and conventional drugs
10/27/1999CN1233177A Therapeutic treatment for VEGF related diseases
10/26/1999US5972593 Method for the photo-decontamination of pathogens in blood using 4'-primary amino psoralens
10/26/1999US5972379 Liposomes having a surface coating of hydrophilic polymer chains and an entrapped ciprofloxacin-amino acid conjugate, useful for treating the bacterial infections
10/21/1999WO1999052565A1 Radionuclide excited phosphorescent material for administering pdt
10/20/1999EP0949932A1 Use of hollow microcapsules in diagnosis and therapy
10/19/1999US5969111 Radiation sensistizers
10/19/1999CA2154913C Magnetically responsive composition for carrying biologically active substances and methods of production and use
10/14/1999WO1999051284A2 Non-covalent bioconjugates useful for diagnosis and therapy
10/14/1999WO1999051277A1 Enhancement of cellular gallium uptake
10/14/1999WO1999051202A2 Quinolone containing liposomes and their use as antibacterial agents
10/14/1999CA2326650A1 Azo and diaza dericatives and uses thereof in phototherapy
10/14/1999CA2326497A1 Liposome composition and method for administering a quinolone
10/14/1999CA2325353A1 Enhancement of cellular gallium uptake
10/13/1999EP0948329A1 Use of green porphyrins for the manufacture of a medicament for the treatment of secondary cataracts
10/12/1999US5965598 Phototherapeutic and photodiagnostic agents as free molecules and as conjugates with macromolecular carrier molecules
10/12/1999US5965349 Methods of photodecontamination using synthetic media
10/12/1999US5965131 Galactosylated clearing agent binds to the primary binding site of the primary targeting species, and only non-bound primary targeting species is cleared, not bound species second site is not blocked by the clearing agent
10/07/1999WO1999049901A1 Water soluble paclitaxel derivatives
10/06/1999EP0947222A2 Method of activating photosensitive agents
10/05/1999US5962424 Inducing selectin expression using ionizing radiation
10/05/1999US5961459 Use of hollow microcapsules in diagnosis and therapy
09/1999
09/30/1999WO1999048527A1 Apo-2 ligand-anti-her-2 antibody synergism
09/30/1999WO1999039765A3 Soft x-ray emitting medical devices
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 95